L
Lexicon Pharmaceuticals, Inc. (LXRX)
NCM – Real Time Price. Currency in USD
2.41
+0.10 (4.33%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.41
+0.10 (4.33%)
At close: May 12, 2026, 4:00 PM EDT
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company develops sotagliflozin, an orally-delivered small molecule drug for the treatment of hypertrophic cardiomyopathy, and ZYNQUISTA (sotagliflozin) for the treatment of type 1 diabetes. It also commercializes INPEFA (sotagliflozin), a once-daily oral tablet to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes, CKD, and other cardiovascular risk factors. In addition, the company develops LX9851, an orally-delivered small molecule drug candidate for the treatment of obesity and associated cardiometabolic disorders, and pilavapadin (LX9211), an orally-delivered small molecule drug candidate for the treatment of neuropathic pain. It has strategic collaboration and license agreements with Viatris Inc. and Bristol-Myers Squibb Company. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
| Name | Position |
|---|---|
| Dr. Craig B. Granowitz M.D., Ph.D. | Senior VP & Chief Medical Officer |
| Dr. Michael S. Exton Ph.D. | CEO & Director |
| Dr. Suma Gopinathan M.S., Ph.D. | Senior Vice President of Discovery |
| Mr. Brian T. Crum | Senior VP, General Counsel & Secretary |
| Mr. Scott M. Coiante | Senior VP & CFO |
| Ms. Kristen L. Alexander | Vice President of Finance & Accounting |
| Ms. Lisa M. DeFrancesco | Senior Vice President of Investor Relations & Corporate Communications |
| Ms. Rachel Yap Martens | Senior VP of Partnerships & Corporate Strategy |
| Ms. Wendy E. McDermott | Senior Vice President of Human Resources |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | lxrx-20260507.htm |
| 2026-05-07 | 10-Q | lxrx-20260331.htm |
| 2026-05-06 | 8-K | lxrx-20260504.htm |
| 2026-04-30 | 8-K | lxrx-20260430.htm |
| 2026-03-16 | DEFA14A | a2026proxynotice04-22x2026.htm |
| 2026-03-16 | ARS | a2025annualreport.htm |
| 2026-03-05 | 8-K | lxrx-20260305.htm |
| 2026-02-17 | PRE 14A | lxrx-20260217.htm |
| 2026-02-17 | D | |
| 2026-02-02 | 8-K | d32395d8k.htm |